208 related articles for article (PubMed ID: 32576334)
1. Sequential introduction of a multistep testing algorithm and nucleic acid amplification testing leading to an increase in
Skinner AM; Yu B; Cheknis A; Pacheco SM; Gerding DN; Johnson S
Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1148-1153. PubMed ID: 32576334
[TBL] [Abstract][Full Text] [Related]
2. Performance of laboratory tests for detection for Clostridioides difficile: A multicenter prospective study in Japan.
Senoh M; Kato H; Honda H; Fukuda T; Tagashira Y; Horiuchi H; Chiba H; Suzuki D; Hosokawa N; Kitazono H; Norisue Y; Kume H; Mori N; Morikawa H; Kashiwagura S; Higuchi A; Kato H; Nakamura M; Ishiguro S; Morita S; Ishikawa H; Watanabe T; Kojima K; Yokomaku I; Bando T; Toimoto K; Moriya K; Kasahara K; Kitada S; Ogawa J; Saito H; Tominaga H; Shimizu Y; Masumoto F; Tadera K; Yoshida J; Kikuchi T; Yoshikawa I; Watanabe T; Honda M; Yokote K; Toyokawa T; Miyazato H; Nakama M; Mahe C; Reske K; Olsen MA; Dubberke ER
Anaerobe; 2019 Dec; 60():102107. PubMed ID: 31647977
[TBL] [Abstract][Full Text] [Related]
3. Implementing a Clostridium difficile testing algorithm and its effect on isolation duration and treatment initiation: a pre- and post-implementation study.
Vogelzang EH; Lankelma JM; van Mansfeld R; van Prehn J; van Houdt R
Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1071-1076. PubMed ID: 31970532
[TBL] [Abstract][Full Text] [Related]
4. Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
Guh AY; Hatfield KM; Winston LG; Martin B; Johnston H; Brousseau G; Farley MM; Wilson L; Perlmutter R; Phipps EC; Dumyati GK; Nelson D; Hatwar T; Kainer MA; Paulick AL; Karlsson M; Gerding DN; McDonald LC
Clin Infect Dis; 2019 Oct; 69(10):1667-1674. PubMed ID: 30615074
[TBL] [Abstract][Full Text] [Related]
5. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.
Landry ML; Topal JE; Estis J; Katzenbach P; Nolan N; Sandlund J
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776192
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and outcomes of
Crone AS; Wright LM; Cheknis A; Johnson S; Pacheco SM; Skinner AM
Infect Control Hosp Epidemiol; 2024 Jan; 45(1):57-62. PubMed ID: 37462099
[TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.
Novak-Weekley SM; Marlowe EM; Miller JM; Cumpio J; Nomura JH; Vance PH; Weissfeld A
J Clin Microbiol; 2010 Mar; 48(3):889-93. PubMed ID: 20071552
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of 4 molecular assays as part of a 2-step algorithm for the detection of Clostridium difficile in stool specimens.
Caulfield AJ; Bolster LaSalle CM; Chang YH; Grys TE
Diagn Microbiol Infect Dis; 2018 May; 91(1):1-5. PubMed ID: 29428547
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness Analysis of Four Common Diagnostic Methods for Clostridioides difficile Infection.
Xuan S; Zangwill KM; Ni W; Ma J; Hay JW
J Gen Intern Med; 2020 Apr; 35(4):1102-1110. PubMed ID: 32016703
[TBL] [Abstract][Full Text] [Related]
10. Impact of the introduction of nucleic acid amplification testing on Clostridioides difficile detection and ribotype distribution in Wales.
Perry MD; White PL; Morris TE
Anaerobe; 2021 Feb; 67():102313. PubMed ID: 33309680
[TBL] [Abstract][Full Text] [Related]
11. A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of
Kraft CS; Parrott JS; Cornish NE; Rubinstein ML; Weissfeld AS; McNult P; Nachamkin I; Humphries RM; Kirn TJ; Dien Bard J; Lutgring JD; Gullett JC; Bittencourt CE; Benson S; Bobenchik AM; Sautter RL; Baselski V; Atlas MC; Marlowe EM; Miller NS; Fischer M; Richter SS; Gilligan P; Snyder JW
Clin Microbiol Rev; 2019 Jun; 32(3):. PubMed ID: 31142497
[TBL] [Abstract][Full Text] [Related]
12. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
Humphries RM; Uslan DZ; Rubin Z
J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
[TBL] [Abstract][Full Text] [Related]
13. Can a toxin gene NAAT be used to predict toxin EIA and the severity of
Garvey MI; Bradley CW; Wilkinson MAC; Holden E
Antimicrob Resist Infect Control; 2017; 6():127. PubMed ID: 29270290
[TBL] [Abstract][Full Text] [Related]
14. Reduction in testing and change in testing algorithm associated with decrease in number of nosocomial Clostridioides (Clostridium) difficile infections.
Cook PP; Nichols S; Coogan M; Opera J; DeHart M
Am J Infect Control; 2020 Sep; 48(9):1019-1022. PubMed ID: 32044135
[TBL] [Abstract][Full Text] [Related]
15. A 2-step algorithm combining glutamate dehydrogenase and nucleic acid amplification tests for the detection of Clostridioides difficile in stool specimens.
Liu C; Tang C; Han Y; Xu Y; Ni F; Jin K; Liu G
Eur J Clin Microbiol Infect Dis; 2021 Feb; 40(2):345-351. PubMed ID: 32944896
[TBL] [Abstract][Full Text] [Related]
16. Effect of testing methods on incidence of
McCauley BP; Evans ME; Simbartl LA; Gamage SD; Kralovic SM; Roselle GA
Infect Control Hosp Epidemiol; 2021 Apr; 42(4):461-463. PubMed ID: 33185177
[TBL] [Abstract][Full Text] [Related]
17. Two-step Testing for Clostridioides Difficile is Inadequate in Differentiating Infection From Colonization in Children.
Parnell JM; Fazili I; Bloch SC; Lacy DB; Garcia-Lopez VA; Bernard R; Skaar EP; Edwards KM; Nicholson MR
J Pediatr Gastroenterol Nutr; 2021 Mar; 72(3):378-383. PubMed ID: 32925555
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of a newly developed high-speed polymerase chain reaction analysis system for the diagnosis of Clostridioides difficile infection.
Furukawa K; Mitsutake H; Aso R; Sekizawa R; Okanda T; Hayashi K; Matsumoto T; Nakamura S
J Infect Chemother; 2021 May; 27(5):715-721. PubMed ID: 33402305
[TBL] [Abstract][Full Text] [Related]
19. Optimizing laboratory workflow for the diagnosis of Clostridiodes difficile infection in a medical center in Northern Taiwan.
Chang FC; Liu CP; Sun FJ; Lin CC
J Microbiol Immunol Infect; 2021 Apr; 54(2):284-289. PubMed ID: 31624018
[TBL] [Abstract][Full Text] [Related]
20. Nucleic Acid Amplification Test Quantitation as Predictor of Toxin Presence in Clostridium difficile Infection.
Crobach MJT; Duszenko N; Terveer EM; Verduin CM; Kuijper EJ
J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29237788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
